- Filed
- Aug 6, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q2 2024 · Mar 31, 2024 | $1.77M |
| Long Term Debt | Q2 2024 · Sep 30, 2023 | $5.4M |
| Short Term Debt | Q2 2024 · Mar 31, 2024 | $2.49M |
| Short Term Debt | Q2 2024 · Sep 30, 2023 | $4.44M |
| Stockholders Equity | Q2 2024 · Mar 31, 2024 | $75.66M |
| Stockholders Equity | Q2 2024 · Sep 30, 2023 | $74.41M |
| Current Liabilities | Q2 2024 · Mar 31, 2024 | $14.84M |
| Current Liabilities | Q2 2024 · Sep 30, 2023 | $22.61M |
| Total Liabilities | Q2 2024 · Mar 31, 2024 | $16.91M |
| Total Liabilities | Q2 2024 · Sep 30, 2023 | $28.33M |
| Current Assets | Q2 2024 · Mar 31, 2024 | $70.26M |
| Current Assets | Q2 2024 · Sep 30, 2023 | $80.24M |
| Total Assets | Q2 2024 · Mar 31, 2024 | $92.86M |
| Total Assets | Q2 2024 · Sep 30, 2023 | $103.01M |
| Cash And Equivalents | Q2 2024 · Sep 30, 2023 | $20.19M |
| Shares Diluted | Q2 2024 · Mar 31, 2023 | 14.03M sh |
| Capex | Q2 2024 · Mar 31, 2023 | $53.91K |
| Operating Cash Flow | Q2 2024 · Mar 31, 2023 | −$565.34K |
| Eps Diluted | Q2 2024 · Mar 31, 2023 | $0.10 |
| Eps Basic | Q2 2024 · Mar 31, 2023 | $0.10 |
| Sga Expense | Q2 2024 · Mar 31, 2023 | $3.73M |
| Rd Expense | Q2 2024 · Mar 31, 2023 | $1.14M |
| Net Income | Q2 2024 · Mar 31, 2023 | $1.44M |
| Operating Income | Q2 2024 · Mar 31, 2023 | $1.45M |
| Gross Profit | Q2 2024 · Mar 31, 2023 | $5.73M |